Biventricular impairment in diastolic function in acromegaly;Alteración de la función diastólica de ambos ventrículos en la acromegalia

Revista Espanola de Cardiologia

Volumn 54, Issue 1, 2001, Pages 37-42

  Ortuño, Francisco Marín ^a   Alfonso, Antonio M Picó ^a   Martínez, Juan G Martínez ^a   Escribano, José R Domínguez ^b   Payá, Vicente E Climent ^a   Rocamora, Javier Pineda ^a   Garri, Francisco Soborg ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b University Hospital San Juan de Alicante   (Spain)

Author keywords

Acromegaly; Diastole; Echocardiography

Indexed keywords

ACROMEGALY; ARTICLE; DIASTOLE; FEMALE; HEART VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ACROMEGALY; DIASTOLE; FEMALE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR FUNCTION;

EID: 0035227818     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(01)76262-8     Document Type: Article

References (24)

1. Melmed S. Acromegaly. N Engl J Med 1990; 322: 966-977.
2. Nabarro JDN. Acromegaly. Clin Endocrinol 1987; 26: 481-512.
3. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994; 15: 555-575.
4. Marín F, Picó AM, Martínez JG, Domínguez JR. Alfayate R, Sogorb F. Alteraciones cardiológicas en la acromegalia. Estudio de 27 pacientes. Med Clin (Barc) 1996; 107; 326-330.
5. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP et al. Differential cardiac effects of growth hormone and insuline-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 1996; 93: 880-889.
6. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B et al. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 1993; 14: 26-33.
7. Joint National Committee on detection, evaluation and treatment of high blood pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
8. World Health Organization. Diabetes mellitus: report of WHO study group. Ginebra, World Health Organization, 1985 (Tech Res Ser, n.o 727).
9. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammon IW et al. Standarization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222-1230.
10. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996; 27: 1753-1760.
11. Dumesnil JG, Gaudreault G, Honos GN, Kingma JC. Use of Valsava maneuver to unmask left ventrcular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol 1991; 68: 515-519.
12. Rodrigues EA, Caruana MP, Lahiri A, Nabarro JDN, Jacobs HS, Raftery EB. Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J 1989; 62: 185-194.
13. Lie JT, Grossman SJ. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980; 100: 41-52.
14. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B et al. Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J 1997; 17: 340-347.
15. Lim MJ, Barkan AL, Buda AJ. Rapid reduction of left ventricular hypetrophy in acromegaly after suppresion of growth hormone hypersecretion. Ann Intern Med 1992; 117: 719-726.
16. Chanson P, Timsit J, Masquet C, Warnet A, Bieman PJ, Harris AG et al. Cardiovascular effects of somatostatin analog octreotide in acromegaly. Ann Intern Med 1990; 113: 921-925.
17. Merola B, Cittadini A, Colao A, Ferone D, Fazio S, Sahatini D et al. Chronic treatment with octreotide improves cardiac abnormalities in patients with acromegaly. J Clin Endocrinol Metab 1993; 77: 790-793.
18. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Nicolai E et al. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994; 79: 441-446.
19. Ozbey N, Oncul A, Bugra Z, Vural A, Erzenguin F, Orhan Y et al. Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage. J Endocrinol Invest 1997; 20: 305-311.
20. Minniti G, Moroni C, Jaffrain-Rea ML, Bondanini F, Gulino A, Cassone R. Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring. Clin Endocrinol Oxf 1998; 48: 149-152.
21. López-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM, Moya-Mur JL. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? J Clin Endocrinol Metab 1997; 82: 1047-1053.
22. a ed.). 1996; 360-394.
23. Neubaur T, Schwartzkopff B, Strauer BE. Right ventricular performance in arterial hypertension. Eur Heart J 1992; 13 (Supl D): 33-38.
24. Gómez LA, García H, Clínica. En: Webb SM, editor. Acromegalia. Madrid: Acción Médica, 1998; 55-83.